Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: Preliminary Analysis from a Phase 2, Prospective, Multicenter Study
机构:[1]Capital Med Univ, Beijing Chao Yang Hosp, Beijing, Peoples R China北京朝阳医院[2]Peking Union Med Coll Hosp, Beijing, Peoples R China[3]Zhengzhou Univ, Dept Hematol, Affiliated Hosp 1, Zhengzhou, Peoples R China[4]First Hosp Jilin Univ, Changchun, Peoples R China[5]Hebei Univ, Affiliated Hosp, Baoding, Peoples R China河北大学附属医院[6]Shanxi Med Univ, Dept Hematol, Hosp 2, Taiyuan, Peoples R China[7]Nantong Univ, Affiliated Hosp, Nantong, Jiangsu, Peoples R China[8]Capital Med Univ, Beijing Luhe Hosp, Dept Hematol, Beijing, Peoples R China[9]Shanxi Prov Canc Hosp, Taiyuan, Peoples R China[10]China Japan Friendship Hosp, Beijing, Peoples R China[11]Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Peoples R China[12]Chinese Peoples Liberat Army Gen Hosp, Dept Lymphoma & Plasma Cell Dis, Med Ctr 5, 8 Dongdajie St, Beijing 100071, Peoples R China[13]Capital Med Univ, Beijing Chao Yang Hosp, Beijing Chao Yang Hosp, Beijing, Peoples R China北京朝阳医院[14]Beijing Chao Yang Hosp, Beijing, Peoples R China北京朝阳医院[15]Peking Univ Third Hosp, Beijing, Peoples R China[16]Guangxi Med Univ, Dept Haematol, Affiliated Hosp 1, Nanning, Peoples R China[17]Shenzhen Peoples Hosp, Dept Hematol, Shenzhen, Peoples R China深圳市人民医院深圳医学信息中心[18]Cangzhou Cent Hosp, Cangzhou, Peoples R China[19]Fujian Med Univ, Fujian Prov Hosp, Fuzhou, Peoples R China[20]Changzhi Med Coll, Heping Hosp, Changzhi, Peoples R China[21]Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, Beijing, Peoples R China北京朝阳医院[22]Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
第一作者机构:[1]Capital Med Univ, Beijing Chao Yang Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Zhou Huixing,Chang Long,Ma Jie,et al.Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: Preliminary Analysis from a Phase 2, Prospective, Multicenter Study[J].BLOOD.2024,144:1978-1979.doi:10.1182/blood-2024-201978.
APA:
Zhou, Huixing,Chang, Long,Ma, Jie,Sun, Jingnan,Xue, Hua...&Gao, Wen.(2024).Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: Preliminary Analysis from a Phase 2, Prospective, Multicenter Study.BLOOD,144,
MLA:
Zhou, Huixing,et al."Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: Preliminary Analysis from a Phase 2, Prospective, Multicenter Study".BLOOD 144.(2024):1978-1979